Capecitabine (Xeloda ™; Roche, Nutley, NJ) is an oral prodrug of 5-fluorourarcil (5-FU) that undergoes a three-step enzymatic activation process to be converted to the active drug. This three ...

Capecitabine (Xeloda) is a type of oral chemotherapy often prescribed to treat metastatic breast cancer. It’s sometimes used alongside targeted therapy, or on its own if the cancer has stopped ...

The most commonly used chemotherapy drugs include: capecitabine (Xeloda) carboplatin (Paraplatin) eribulin (Halaven) gemcitabine (Gemzar) paclitaxel (Taxol) vinorelbine (Navelbine) Side effects of ...

The physician's choice of therapy included Novartis' EGFR/HER2 inhibitor Tykerb (lapatinib) plus Roche's chemotherapeutic drug Xeloda (capecitabine), or Roche's HER2 therapy Herceptin (trastuzumab ...

a taxane and capecitabine (Xeloda; Roche). On average, the women had received seven drugs to treat their metastatic disease prior to receiving T–DM1. “One of the reasons that we think that ...

For example, the CAIRO2 trial showed that addition of cetuximab to capecitabine (Xeloda; Roche), oxaliplatin and bevacizumab resulted in significantly shorter progression-free survival and ...

tucatinib in combination with trastuzumab (Herceptin®) and capecitabine (Xeloda®) in heavily pre-treated patients with advanced HER2+ breast cancer with or without brain metastases (ONT-380-005 ...